Promotion of a quality standard for Paris polyphylla var. yunnanensis based on the efficacy-oriented effect-constituent index

J Pharm Biomed Anal. 2024 Jan 20:238:115843. doi: 10.1016/j.jpba.2023.115843. Epub 2023 Nov 8.

Abstract

Multi-component determination and bioassays used for the quality control of traditional Chinese medicine (TCM) may have certain shortcomings. The effect-constituent index (ECI) is a quality evaluation index weighted by chemical composition analysis and effect detection. This index can be established by the dose-effect relationship of the active ingredients in TCM. In this study, Paris polyphylla var. yunnanensis (PY) was selected as the representative drug. Chemical evaluation and bioactivity evaluation were combined to establish the ECI, to compensate for the deficiency of a single evaluation method to some extent, and can be related to the efficacy of PY, in order to improve its quality standard. The ECI not only reflects the contribution of component content to the quality of PY, but also relates to clinical efficacy and reflects the influence of different components on the biological activity. Moreover, this study provided a reference method for the quality control of other TCMs.

Keywords: Bioactivity evaluation; Chemical evaluation; Effect-constituent index; HepG2 cell; Paris polyphylla var. yunnanensis.

MeSH terms

  • Ascomycota*
  • Liliaceae* / chemistry
  • Medicine, Chinese Traditional
  • Melanthiaceae*
  • Quality Control